alcoholic fatty liver


Also found in: Dictionary, Thesaurus, Acronyms.
Related to alcoholic fatty liver: Alcoholic hepatitis

alcoholic fatty liver

A liver with acute and subacute (i.e., precirrhotic) changes induced by alcohol, a toxin that interferes with fatty acid oxidation, impairing the tricarboxylic acid cycle, resulting in incomplete beta-oxidation products from fatty acids.

alcoholic fatty liver

A liver with acute and subacute, ie precirrhotic, changes induced by alcohol, a toxin that interferes with fatty acid oxidation, impairing the tricarboxylic acid cycle, resulting in incomplete β-oxidation products from fatty acids. See Alcoholic cirrhosis. Cf Fatty liver of pregnancy.
References in periodicals archive ?
The report reviews key players involved Non Alcoholic Fatty Liver Disease (NAFLD) therapeutics and enlists all their major and minor projects
According to the limited data available, the prevalence of non- alcoholic fatty liver ranges from 15 to 32 per cent in India.
Alcoholic fatty liver was thought to be relatively benign in the past, but more recent studies have shown that the disease is apt to develop inflammation, necrosis, fibrosis and final cirrhosis, and the lipid accumulation renders the liver more susceptible to injury by some agents such as drugs and toxins (Diehl 2001).
A review of the Non Alcoholic Fatty Liver Disease (NAFLD) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
The report reviews key players involved in the therapeutics development for Non Alcoholic Fatty Liver Disease (NAFLD) and enlists all their major and minor projects
Since the unbalanced dietary consumption of n-6:n-3 PUFA is detrimental to human health, the impact of dietary supplementation with n-3 PUFA upon the alleviation of inflammatory diseases, more specifically, non alcoholic fatty liver disease, needs to be more thoroughly investigated.
Objective: To determine frequency of Non Alcoholic fatty liver disease in patients with Metabolic Syndrome (MetS).
A recent issue of the American Journal of Physiology-Gastrointestinal and Liver Physiology reported the finding of researchers at the University of South Florida Health Sciences Center in Tampa of a protective effect for resveratrol against alcoholic fatty liver disease in mice.
TABLE 26 GALLSTONE SOLUBILIZING AGENTS USED TO TREAT NON- ALCOHOLIC FATTY LIVER DISEASE 47
The most significant liver diseases are hepatitis, non alcoholic fatty liver disease (NAFLD), non-alcoholic fatty liver steatohepatitis (NASH), carcinoma and cirrhosis.